James Akman retweetledi

Very exciting news for patients with cisplatin-ineligible MIBC!! EV/P approved today!
#EV303
80% T3-T4a
12% ECOG 2
EFS 0.40
OS 0.50
pCR 57% vs 8.6%
❓could we preserve some of these bladders
❓extrapolate #Imvigor011 using ctDNA to guide adjuvant tx? #MODERN will help




English































